GU2-30639-01576
3 vaccinations
3 coded responses
28 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 232 / VA
- Registered
- 2021-03-06
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-06
Registered in v-safe
-
2021-03-06
Dose 1 — Moderna
- 2021-03-06
-
2021-03-07
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Swelling · Headache, Fatigue or tirednessAdult check-in
- 2021-03-08
- 2021-03-09
- 2021-03-10
- 2021-03-11
- 2021-03-12
- 2021-03-16
- 2021-03-20
- 2021-03-27
-
2021-04-03
Dose 2 — Moderna
-
2021-04-03
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain, Itching · Headache, Fatigue or tirednessAdult check-in
-
2021-04-04
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-05
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-04-06
-
2021-04-07
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Itching · HeadacheAdult check-in
- 2021-04-08
- 2021-04-09
- 2021-04-10
- 2021-04-17
- 2021-04-24
- 2021-05-01
- 2021-05-08
- 2021-05-16
- 2021-07-03
- 2021-10-02
-
2022-01-07
Dose 3 — Moderna
-
2022-04-03
Survey response — 12 months, dose 2MedDRA: Urticarial dermatitis — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: dermatitis urticariaMedDRA releases: 2024-11 · check-in free text available
-
2022-04-03
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-04-06
-
2022-04-08
Call successfulParticipant prefers to complete VAERS report online
-
2022-07-08
Survey response — 6 months, dose 3MedDRA: Urticaria — Feeling: FairFree text: UrticariaMedDRA releases: 2024-11 · check-in free text available
-
2023-01-08
Survey response — 12 months, dose 3MedDRA: Mechanical urticaria — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-01-08
Report sent to call center — 12 months, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2023-01-09
- 2023-01-18
-
2023-01-19
Callback requested for05:00PM ET
-
2023-01-19
Call successfulCompleted over the phone
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-06 | Moderna | |
| 2 | 2021-04-03 | Moderna | |
| 3 | 2022-01-07 | Moderna | No |
Call center
2 call center cases
2 successful
VAERS report filed, before or during a call: 1
Free text
Release 11 — 12 months, dose 2
Symptoms: dermatitis urticaria
Release 12 — 6 months, dose 3
Symptoms: Urticaria
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Mechanical urticaria | · | · | ✓ |
| SD | Urticaria | · | · | ✓ |
| SD | Urticarial dermatitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release